FMC/Alemtuzumab Regimen

Preferred Label : FMC/Alemtuzumab Regimen;

NCIt synonyms : FMC-Alemtuzumab; Alemtuzumab/Cyclophosphamide/Fludarabine/Mitoxantrone; FMC Plus Alemtuzumab; Fludarabine/Mitoxantrone/Cyclophosphamide/Alemtuzumab; Alemtuzumab-FMC;

NCIt definition : A regimen consisting of cyclophosphamide, fludarabine, mitoxantrone and alemtuzumab that may be used in the treatment of T-cell prolymphocytic leukemia.;

NCI Metathesaurus CUI : CL1905249;

Détails

Origin ID

C191716;

UMLS CUI

C5784678;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Alemtuzumab [NCIt concept]
- Cyclophosphamide [NCIt concept]
- Fludarabine Phosphate [NCIt concept]
- Mitoxantrone [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients